hepatitis
The latest news on hepatitis
Testing needs to ensure vaccine blocked mother-to-child transmission of virus
But measles, chickenpox protection remains a concern
What’s behind the latest obesity rates; why dieting can make you fat
Most people who are infected don't know it, agency noted
NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. is suspending a midstage study of a potential hepatitis C treatment because of a serious patient safety issue.
Study findings indicate even ex-smokers were more likely to be re-infected within 1 year
Small study suggests a benefit, but experts are more cautious about the results
Blacks, men, people with HIV had more virus, which affects treatment response: CDC
Los Angeles study finds nearly half don't know it
Study finds majority of cases are foreign-born residents
